Showing results (1771-1780 of 1,830) with videos related to

Sort By:
Pageof 183
Scientific Reports|July 13, 2017
Identification of FBXL4 as a Metastasis Associated Gene in Prostate CancerElzbieta Stankiewicz, Xueying Mao, D Chas Mangham, et al.
Radiology|July 1, 2005
Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III studyJoseph H Rapp, Steven D Wolff, Stephen F Quinn, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 24, 2017
A critical role for donor-derived IL-22 in cutaneous chronic GVHDKate H Gartlan, Hemamalini Bommiasamy, Katelyn Paz, et al.
Scientific Reports|April 16, 2024
Measuring social determinants of health in the All of Us Research ProgramSamantha Tesfaye, Robert M Cronin, Maria Lopez-Class, et al.
Prostate Cancer and Prostatic Diseases|February 24, 2010
The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancerL Shan, L Ambroisine, J Clark, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2019
Symbiotic organs shaped by distinct modes of genome evolution in cephalopodsMahdi Belcaid, Giorgio Casaburi, Sarah J McAnulty, et al.
Frontiers in Immunology|January 23, 2023
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsiaGrace L Burns, Jessica K Bruce, Kyra Minahan, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2007
Investigation of the terminal P4 domain in a series of D-phenylglycinamide-based factor Xa inhibitorsJeffry B Franciskovich, John J Masters, Wayne W Weber, et al.
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.
Ophthalmology|September 22, 2010
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) studyQuan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, et al.
Pageof 183